This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The healthcare industry of the future will be defined by interoperable systems that need to securely share critical data across devices, distributed applications, and networks. Device manufacturers play a pivotal role in the delivery of these secure and connected solutions
America’s Health Insurance Plans’ new campaign aims to show how health insurers are working to create savings for Americans while also targeting Big Pharma (or more specifically drug manufacturers) for increasing drug costs. The ads will be distributed on TV, social media and streaming services.
Researchers have developed a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can extract the particle size distribution (PSD) of a pharmaceutical powder surface from its laser speckle. This limits its application to surfaces encountered in pharmaceuticals manufacturing. Zhang et al.
The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. During the earlier announcement for its French facility, Orano Med highlighted one key challenge of developing lead-212 based radioligand therapies is manufacturing then on an industrial scale.
A dedicated Case Manager provides end-to-end supply chain management and 24/7 oversight and support to help ensure the seamless manufacturing and distribution of each therapy dose to every patient.
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.
Orano Med (a subsidiary of the Orano Group), has begun to build a new manufacturing site for targeted alpha therapies (TAT) for oncology indications. So construction of the new radioligand therapy manufacturing site in France is a major step towards making these promising new treatments available to cancer patients with high unmet needs.
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. WuXi STA has 12 sites across the US, Europe and Asia. WuXi STA has 12 sites across the US, Europe and Asia.
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.
On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. This is important due to the UK’s currently limited short-scale manufacturing capacity.
However, the biopharma industries realised that traditional vaccine development and manufacturing techniques, which take around five to 10 years for initial development to large-scale distribution, 1 were inadequate to meet the growing demand for COVID-19 vaccines. Digital technologies for smart vaccine manufacturing.
Understanding how the worldwide distribution ecosystem works is a must for any MedTech professional. This conversation with Daniel Cloutier provides a window into this world and how LOK brings value to the manufacturers it represents with turnkey distribution. Reading time: 2 – 2 minutes. Now Go Win Your Week!
10 No manufacturing, packaging, or distribution of Humira or related inputs occurs in Bermuda. operates through a branch in Puerto Rico that manufactures the Humira bulk drug substance and a fill-finish operation in which the bulk drug substance is filled into syringes or injectable pens.12 AbbVie Biotechnology Ltd. in the U.S.,
In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The post How can PAT help advance biologics manufacturing? appeared first on European Pharmaceutical Review.
2,3 Clinical implementation of CAR T-cell technology requires a reproducible T-cell manufacturing platform, which necessitates effective gene-transfer tools and T-cell culture conditions. Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks.
A paper published in Frontiers in Microbiology has described an innovative strategy for microbial identification and contamination investigation during sterile manufacturing of drugs. Further examination of the contamination distribution in different grade areas indicated that the highest rate (52 percent) was found in grade C clean areas.
The initial agreement between Dyadic and Rubic involved discovery, development, manufacturing, and distribution of Covid-19 vaccines by transferring and licensing of C1 platform technology. During the Covid-19 pandemic, vaccination rates of many countries in Africa were significantly trailing the rest of the world.
The World Health Organization (WHO)’s Global Vaccine Market Report 2022 , the first report to examine the impact of COVID-19 on the global vaccine market, shows that inequitable distribution is not unique to COVID-19 vaccines, with poorer countries consistently fighting to access vaccines in demand by wealthier countries.
There is a good chance you are either a manufacturer that exports product to international markets or a distributor that is representing a manufacturer. Non-US manufacturers are much more sensitive to their international distribution networks. Offer to create an eNewsletter they can distribute to their end users.
Emergence of advanced manufacturing technology to ensure quality of biopharmaceutical drugs combined with efforts to identify a regulatory pathway indicate that a distributedmanufacturing model is within reach.
From automation and Artificial Intelligence (AI) to Blockchain and advanced analytics, these technologies offer unprecedented opportunities to enhance data integrity throughout the manufacturing lifecycle. The post A holistic approach to safeguard data integrity in Biopharma manufacturing appeared first on European Pharmaceutical Review.
This white paper dives into vaccine distribution plans and what vaccine manufacturers, distributors and administrators can take away from this monumental time in both the industry and history. Delivering COVID-19 vaccines to 7.8 billion people was a daunting challenge that stretched supply chains past their limits.
The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure’s AVT02 (adalimumab). Under the licence agreement for the antibody, Alvotech will be responsible for the development and manufacturing, while Bioventure will handle the marketing.
The US Food and Drug Administration (FDA) approved Kamada’s application to manufacture Cytogam (cytomegalovirus immune globulin intravenous [human]) at its facility located in Beit Kama, Israel. The regulatory approval represents the completion of the Cytogam technology transfer process from CSL Behring, its previous manufacturer.
But new legislation coming in 2025 will allow 3D printing as part of a distributedmanufacturing framework. 3D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation.
Water, fertilizers, and other inputs are judiciously distributed, ensuring crops receive precisely what they need, when they need it. The percentage of food insecure household was statistically significantly higher than the 10.2 percent recorded in 2021 (13.5 million households) and the 10.5 percent in 2020 (13.8 million households).
Providing ‘how to’ videos and wikis available at the point of use for the system, rather than relying on distributing printouts of long and complex written standard operating procedures (SOPs). The post GAMP 5 update: computerized system expectations for pharma manufacturers appeared first on European Pharmaceutical Review.
Three trade bodies representing vaccine creators and manufacturers are endorsing The Berlin Declaration framework , a proposal that outlines how the industry would reserve an allocation of real-time vaccine production for swift distribution to priority populations in lower-income countries in future pandemics.
The affected product was distributed nationwide to wholesalers, hospitals and Department of Defense in the US between 10 June 2020 and 26 June 2020. Wholesalers or hospitals with an existing inventory of the lot should stop use and distribution and quarantine immediately. The full details are listed below: Products. Lot Number.
After these dates, the FDA will begin enforcing the normal regulatory restrictions on compounded drugs, and manufacturing or distributing compounded semaglutide injections will be considered a violation of the FD&C Act. What About Other GLP-1 Products?
At least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), mainly Africa, are set to benefit from Eli Lilly and Company and manufacturer EVA Pharmaceutical’s new collaboration delivering a sustainable supply of high-quality, affordable human and analogue insulin to this population.
A market report has shown that to improve efficiency, quality and to reduce costs in drug manufacturing , Pharma has been adopting automated quality management systems, digitalisation of processes and integration of data analytics. billion by 2031. billion by 2031. This is compared to a value of $1.48 billion in 2022.
Spectroscopic imaging and mapping offer label-free approaches to probe pharmaceutical tablets and visualise the identity of their components, spatial distributions, domain sizes and shapes. It is widely accepted that the distribution of components throughout a tablet is important to ensure that reliable quality medicines are produced.
French biopharmaceutical company ORPHELIA Pharma has entered an exclusive agreement with Tanner Pharma Group to manage the supply and distribution of Ped-TMZ, also known as Kimozo (temozolomide 40mg/ml, oral suspension) in European countries.
Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution. While using renewable energy for manufacturing will help with green credentials, some producers are also considering continuous manufacturing.
Prior to selling drugs or medical products in any country, pharmaceutical companies must prove compliance and gain the regulatory approval required by the country in which the goods will be distributed in. So, with mandates in place, how do manufacturing facilities meet these compliance goals? Cybersecurity and non-conformance.
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulation (“FDF”) and active pharmaceutical ingredients (“APIs”). We market and distribute our products in over 40 countries.
Intas Pharmaceuticals Ltd- (45 positions) Walk-In Interviews for Multiple Positions On 5th March 2023 Job Description Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company.
Aseptic is best applied to smaller, discrete techniques, behaviours and/or processes, eg, aseptic manufacturing and aseptic process simulation. The very linkages between each manufacturing control lacks proper understanding and awareness of aseptic techniques. The term ‘sterile’ is not to be used casually.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content